Home / Articles / Small synthetic molecules with antiglycation activity. Structure--activity relationship

Small synthetic molecules with antiglycation activity. Structure--activity relationship

Konstantin Valer'evich Savateev 1, 
Konstantin Valer'evich Savateev
Alexander Alekseevich Spasov 2, 
Alexander Alekseevich Spasov
1 Ural Federal University named after the First President of Russia B. N. Yeltsin, Ekaterinburg
2 Volgograd State Medical University
Published 30 November 2021
21
Cite this
GOST
 | 
Cite this
GOST
Savateev K. V., Spasov A. A., Rusinov V. L. Small synthetic molecules with antiglycation activity. Structure--activity relationship // Russian Chemical Reviews. 2021. Vol. 91. No. 6. RCR5041
GOST all authors (up to 50)
Savateev K. V., Spasov A. A., Rusinov V. L. Small synthetic molecules with antiglycation activity. Structure--activity relationship // Russian Chemical Reviews. 2021. Vol. 91. No. 6. RCR5041
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.1070/RCR5041
UR - https://rcr.colab.ws/publications/10.1070/RCR5041
TI - Small synthetic molecules with antiglycation activity. Structure--activity relationship
T2 - Russian Chemical Reviews
AU - Savateev, Konstantin Valer'evich
AU - Spasov, Alexander Alekseevich
AU - Rusinov, Vladimir Leonidovich
PY - 2021
DA - 2021/11/30
PB - ANO Editorial Board of the journal Uspekhi Khimii
SP - RCR5041
IS - 6
VL - 91
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors)
@article{2021_Savateev,
author = {Konstantin Valer'evich Savateev and Alexander Alekseevich Spasov and Vladimir Leonidovich Rusinov},
title = {Small synthetic molecules with antiglycation activity. Structure--activity relationship},
journal = {Russian Chemical Reviews},
year = {2021},
volume = {91},
publisher = {ANO Editorial Board of the journal Uspekhi Khimii},
month = {Nov},
url = {https://rcr.colab.ws/publications/10.1070/RCR5041},
number = {6},
doi = {10.1070/RCR5041}
}
MLA
Cite this
MLA
Savateev, Konstantin Valer'evich, et al. “Small synthetic molecules with antiglycation activity. Structure--activity relationship.” Russian Chemical Reviews, vol. 91, no. 6, Nov. 2021, p. RCR5041. https://rcr.colab.ws/publications/10.1070/RCR5041.
Views / Downloads
53 / 36

Abstract

The accumulation of advanced glycation end products (AGEs) is currently considered as one of the key factors in aging processes, the pathogenesis of late complications of diabetes mellitus, cancer and neurodegenerative diseases. This review is devoted to small synthetic molecules with antiglycation activity, \emph{i.e}., compounds with the ability to inhibit AGE formation. Molecules with antiglycation activity in the low micromolar range ($<$10 $\mu$M), primarily fused heterocyclic systems containing oxygen or nitrogen as heteroatoms and (thio)ureas, have been discovered to date. The known scaffolds with antiglycation activity are analyzed, structural modifications to enhance antiglycation abilities are highlighted and the structure--activity relationships are discussed. The bibliography includes 125 references.

Keywords

advanced glycation end products
antiglycation activity
diabetes mellitus
structure-activity relationship

Funders

Ministry of Education and Science of the Russian Federation
075-15-2020-777

References

1.
rcr_91_6_RCR5041bib1
2019
2.
rcr_91_6_RCR5041bib2
Shoback
2011
4.
Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus.
Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A.
New England Journal of Medicine , 1976
5.
Failure to reach target glycated a1c levels among patients with diabetes who are adherent to their antidiabetic medication.
6.
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
Yan S., Chen X., Walker D., Schmidt A., Arancio O., Lue L.
Current Molecular Medicine , 2007
7.
Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
Bellier J., Nokin M., Lardé E., Karoyan P., Peulen O., Castronovo V., Bellahcène A.
Diabetes Research and Clinical Practice , 2019
9.
Novel advances in inhibiting advanced glycation end product formation using natural compounds
Song Q., Liu J., Dong L., Wang X., Zhang X.
Biomedicine and Pharmacotherapy , 2021
10.
The Road to Advanced Glycation End Products: A Mechanistic Perspective
Cho S.-., Roman G., Yeboah F., Konishi Y.
Current Medicinal Chemistry , 2007
12.
Semicarbazide‐sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes‐like complications
M. Stolen C., Madanat R., Marti L., Kari S., G. Yegutkin G., Sariola H., Zorzano A., Jalkanen S.
FASEB Journal , 2004
15.
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
Chiappalupi S., Salvadori L., Vukasinovic A., Donato R., Sorci G., Riuzzi F.
Life Sciences , 2021
16.
Dietary Advanced Glycation End Products and Aging
Luevano-Contreras C., Chapman-Novakofski K.
Nutrients , 2010
17.
Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearance
19.
rcr_91_6_RCR5041bib19
Mehanna
Future Med. Chem. , 2013
20.
Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta
Matsui T., Nakamura N., Ojima A., Nishino Y., Yamagishi S.-.
Nutrition, Metabolism and Cardiovascular Diseases , 2016
21.
Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention
Brings S., Fleming T., Freichel M., Muckenthaler M., Herzig S., Nawroth P.
International Journal of Molecular Sciences , 2017
22.
Effect of Metformin on Methylglyoxal Metabolism in Patients with Type 2 Diabetes
Kender Z., Fleming T., Kopf S., Torzsa P., Grolmusz V., Herzig S., Schleicher E., Rácz K., Reismann P., Nawroth P.
Experimental and Clinical Endocrinology and Diabetes , 2014
23.
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
Freedman B.I., Wuerth J., Cartwright K., Bain R.P., Dippe S., Hershon K., Mooradian A.D., Spinowitz B.S.
Controlled Clinical Trials , 1999
24.
Clove (Syzygium aromaticum) spices: a review on their bioactivities, current use, and potential application in dairy products
Idowu S., Adekoya A.E., Igiehon O.O., Idowu A.T.
Journal of Food Measurement and Characterization , 2021
25.
A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds
Anwar S., Khan S., Almatroudi A., Khan A.A., Alsahli M.A., Almatroodi S.A., Rahmani A.H.
Molecular Biology Reports , 2021
26.
Pectins from fruits: Relationships between extraction methods, structural characteristics, and functional properties
Cui J., Zhao C., Feng L., Han Y., Du H., Xiao H., Zheng J.
Trends in Food Science and Technology , 2021
27.
Benzisoxazole: a privileged scaffold for medicinal chemistry
Rakesh K.P., Shantharam C.S., Sridhara M.B., Manukumar H.M., Qin H.
MedChemComm , 2017
28.
Schiff bases in medicinal chemistry: a patent review (2010-2015)
Hameed A., al-Rashida M., Uroos M., Abid Ali S., Khan K.M.
Expert Opinion on Therapeutic Patents , 2016
29.
rcr_91_6_RCR5041bib29
He
Biomed. Pharmacother. , 2020
31.
rcr_91_6_RCR5041bib31
Jahan
Expert Opin. Ther. Pat. , 2015
32.
rcr_91_6_RCR5041bib32
Spassov
Acta Biomed. Sci. , 2021
33.
Unsymmetrically disubstituted urea derivatives: A potent class of antiglycating agents
Khan K.M., Saeed S., Ali M., Gohar M., Zahid J., Khan A., Perveen S., Choudhary M.I.
Bioorganic and Medicinal Chemistry , 2009
34.
rcr_91_6_RCR5041bib34
Perveen
J. Chem. Soc. Pakistan , 2013
37.
rcr_91_6_RCR5041bib37
Shantharam
Int. J. Chem. Pharm. Sci. , 2013
38.
Inhibition of protein glycation by urea and thiourea derivatives of glycine/proline conjugated benzisoxazole analogue – Synthesis and structure–activity studies
39.
Design and synthesis of amino acids-conjugated heterocycle derived ureas/thioureas as potent inhibitors of protein glycation
Shantharam C.S., Suyoga Vardhan D.M., Suhas R., Channe Gowda D.
Russian Journal of Bioorganic Chemistry , 2014
41.
rcr_91_6_RCR5041bib41
Abbasi
Pakistan J. Pharm. Sci. , 2020
42.
Synthesis of 2,4,6-Trichlorophenyl Hydrazones and their Inhibitory Potential Against Glycation of Protein
Mohammed Khan K., Shah Z., Uddin Ahmad V., Khan M., Taha M., Rahim F., Jahan H., Perveen S., Iqbal Choudhary M.
Medicinal Chemistry , 2011
43.
Synthesis of Benzophenonehydrazone Schiff Bases and their In Vitro Antiglycating Activities
Mohammed Khan K., Rahim F., Ambreen N., Taha M., Khan M., Jahan H., Najeebullah, Shaikh A., Iqbal S., Perveen S., Iqbal Choudhary M.
Medicinal Chemistry , 2013
44.
rcr_91_6_RCR5041bib44
Khan
J. Chem. Soc. Pakistan , 2013
45.
rcr_91_6_RCR5041bib45
Qurrat-ul-Ain
J. Chem. Soc. Pakistan , 2016
46.
Substituted benzenediol Schiff bases as promising new anti-glycation agents
Choudhary M.I., Abbas G., Ali S., Shuja S., Khalid N., Khan K.M., Atta-ur-Rahman, Basha F.Z.
Journal of Enzyme Inhibition and Medicinal Chemistry , 2010
47.
Novel ferrocene-based inhibitor of proteins glycation
Milaeva E.R., Shpakovsky D.B., Meleshonkova N.N., Orlova S.I., Shevtsova E.F., Dubova L.G., Kireeva E.G., Kosolapov V.A., Kusnetsova V.A., Sorotsky D.V., Solov’eva O.A., Spasov A.A.
Russian Chemical Bulletin , 2015
48.
Novel diphenylsulfimide antioxidants containing 2,6-di-tert-butylphenol moieties
Milaeva E.R., Shpakovsky D.B., Maklakova I.A., Rufanov K.A., Neganova M.E., Shevtsova E.F., Churakov A.V., Babkova V.A., Babkov D.A., Kosolapov V.A., Spasov A.A.
Russian Chemical Bulletin , 2018
49.
Ultrasonic synthesis of tyramine derivatives as novel inhibitors of α-glucosidase in vitro
Siddiqui H., Bashir M.A., Javaid K., Nizamani A., Bano H., Yousuf S., Rahman A., Choudhary M.I.
Journal of Enzyme Inhibition and Medicinal Chemistry , 2016
50.
rcr_91_6_RCR5041bib50
Yogesh
RSC Adv. , 2015
51.
In vitro Anti-glycation and Anti-oxidant Properties of Synthesized Schiff Bases
Jhaumeer-Laulloo S., Gupta Bhowon M., Mungur S., Fawzi Mahomoodally M., Hussein Subratty A.
Medicinal Chemistry , 2012
54.
rcr_91_6_RCR5041bib54
Zhang
Evidence Based Complement. Altern. Med. , 2013
55.
Evaluation of 4-alkoxychalcones as a new class of antiglycating agents: a combined experimental and docking study
56.
Evaluation of in vivo hypoglycemic potential of 4-ethyloxychalcone in alloxan-induced diabetic rats
Murtaza B., Abbas A., Aslam A., Akhtar M.S., Bashir S., Khalid M., Naseer M.M.
Research on Chemical Intermediates , 2015
57.
Synthesis of β -Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities
Banuppriya G., Sribalan R., Fathima S.A., Padmini V.
Chemistry and Biodiversity , 2018
59.
Synthesis and pharmacological activity of 3-phenoxybenzoic acid derivatives
Spasov A.A., Popov Y.V., Lobasenko V.S., Korchagina T.K., Vassiliev P.M., Kuznetsova V.A., Brigadirova A.A., Rashchenko A.I., Babkov D.A., Kochetkov A.N., Kovaleva A.I., Efremova O.S.
Russian Journal of Bioorganic Chemistry , 2017
61.
rcr_91_6_RCR5041bib61
Tan
Asia Pac. J. Clin. Nutr. , 2008
62.
rcr_91_6_RCR5041bib62
Chilukuri
RSC Adv. , 2015
63.
Metronidazole Esters: A New Class of Antiglycation Agents
Zeb A., Malik I., Rasheed S., Iqbal Choudhary M., Z. Basha F.
Medicinal Chemistry , 2012
64.
Antiglycation Activity of Triazole Schiff’s Bases Against Fructosemediated Glycation: In Vitro and In Silico Study
Shaikh M., Siddiqui S., Zafar H., Naqeeb U., Subzwari F., Imad R., Khan K.M., Choudhary M.I.
Medicinal Chemistry , 2019
65.
Synthesis of phenyl thiazole hydrazones and their activity against glycation of proteins
Khan K.M., Irfan M., Ashraf M., Taha M., Saad S.M., Perveen S., Choudhary M.I.
Medicinal Chemistry Research , 2015
67.
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential
Taha M., Ismail N.H., Jamil W., Imran S., Rahim F., Kashif S.M., Zulkefeli M.
Medicinal Chemistry Research , 2015
68.
Design, synthesis and evaluation of phenylfuroxan nitric oxide-donor phenols as potential anti-diabetic agents
Xie Y., Shao L., Wang Q., Bai Y., Li N., Yang G., Li Y., Bian X.
Bioorganic Chemistry , 2019
69.
Hydroxytyrosol nicotinate, a new multifunctional hypolipidemic and hypoglycemic agent
Xie Y., Chen Z., Li N., Lu W., Xu Y., Lin Y., Shao L., Wang Q., Guo L., Gao Y., Yang G., Li Y., Bian X.
Biomedicine and Pharmacotherapy , 2018
70.
Evaluation of N-Hydroxy-, N-Metoxy-, and N-Acetoxybenzoyl-Substituted Derivatives of Thymine and Uracil as New Substances for Prevention and Treatment of Long-Term Complications of Diabetes Mellitus
Spasov A.A., Brel A.K., Litvinov R.A., Lisina S.V., Kucheryavenko A.F., Budaeva Y.N., Salaznikova O.A., Rashchenko A.I., Shamshina D.D., Batrakov V.V., Ivanov A.V.
Russian Journal of Bioorganic Chemistry , 2018
71.
Synthesis and Antiglycation Activity of Novel S-Carboxyalkyl Derivatives of 2-Thiouracil
Spasov A.A., Geisman A.N., Kosolapov V.A., Babkov D.A., Rashchenko A.I., Babkova V.A., Zakhar’yashcheva O.Y., Ozerov A.A.
Pharmaceutical Chemistry Journal , 2019
72.
Uracil Hydroxybenzamides as Potential Antidiabetic Prodrugs
Brel’ A.K., Spasov A.A., Lisina S.V., Popov S.S., Kucheryavenko A.F., Litvinov R.A., Salaznikova O.A., Rashchenko A.I.
Pharmaceutical Chemistry Journal , 2019
73.
In silico consensus activity prediction, rational synthesis, and evaluation of antiglycation and antiplatelet activities of 3,6-disubstituted 1,2,4,5-tetrazines
Ishmetova R.I., Babkov D.A., Kucheryavenko A.F., Babkova V.A., Sirotenko V.S., Ignatenko N.K., Tolschina S.G., Vassiliev P.M., Rusinov G.L., Spasov A.A.
Russian Chemical Bulletin , 2020
74.
Antiglycation Activity of Quinoline Derivatives- A New Therapeutic Class for the Management of Type 2 Diabetes Complications
Bano B., Abbasi S., Khan J., Hussain S., Rasheed S., Perveen S., Khan K., Choudhary M.
Medicinal Chemistry , 2014
75.
Synthesis and In Vitro Evaluation of Novel 1, 2, 4-Triazole Derivatives as Antifungal Agents
Kokil G., Rewatkar P., Gosain S., Aggarwal S., Verma A., Kalra A., Thareja S.
Letters in Drug Design and Discovery , 2009
76.
Schiff Bases of Istain: Antiglycation Activity
Khan K., Mughal U., Ambreen N., Khan A., Perveen S., Choudhary M.I.
Letters in Drug Design and Discovery , 2009
77.
Synthesis of bis-Schiff bases of isatins and their antiglycation activity
Khan K.M., Khan M., Ali M., Taha M., Rasheed S., Perveen S., Choudhary M.I.
Bioorganic and Medicinal Chemistry , 2009
78.
N-Aroylated Isatins: Antiglycation Activity
Khan K., Mughal U., Khan A., Naz F., Perveen S., Choudhary M.
Letters in Drug Design and Discovery , 2010
79.
Oxindole Derivatives: Synthesis and Antiglycation Activity
Khan K., Khan M., Ambreen N., Taha M., Rahim F., Rasheed S., Saied S., Shafi H., Perveen S., Choudhary M.
Medicinal Chemistry , 2013
80.
Oxindole-based chalcones: synthesis and their activity against glycation of proteins
Khan A., Khan A., Farooq U., Taha M., Shah S.A., Halim S.A., Akram A., Khan M.Z., Jan A.K., Al-Harrasi A.
Medicinal Chemistry Research , 2019
85.
Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities
Taha M., Ismail N.H., Jamil W., Rashwan H., Kashif S.M., Sain A.A., Adenan M.I., Anouar E.H., Ali M., Rahim F., Khan K.M.
European Journal of Medicinal Chemistry , 2014
86.
Synthesis, antiglycation and antioxidant potentials of benzimidazole derivatives
Taha M., Mosaddik A., Rahim F., Ali S., Ibrahim M., Almandil N.B.
Journal of King Saud University - Science , 2020
87.
1-Substituted 2-Benzylaminobenzimidazoles with Phenyl Methoxyls: Synthesis, Computer Prediction, and Pharmacological Activity
Zhukovskaya O.N., Anisimova V.A., Spasov A.A., Vasil’ev P.M., Kosolapov V.A., Kucheryavenko A.F., Gurova N.A., Naumenko L.V., Kuznetsova V.A., Sorotskii D.V., Solov’eva O.A., Reznikov E.V., Gurova V.V., Sirotenko V.S.
Pharmaceutical Chemistry Journal , 2016
88.
Synthesis and Pharmacological Activity of C(2)-Substituted Benzimidazoles
Zhukovskaya O.N., Spasov A.A., Yakovlev D.S., Kosolapov V.A., Mal’tsev D.V., Morkovnik A.S., Babkova V.A., Brigadirova A.A., Agatsarskaya Y.V., Taran A.S., Miroshnikov M.V., Sultanova K.T., Kornilov V.I., Anisimova V.A.
Pharmaceutical Chemistry Journal , 2019
89.
2-Amino- and 2-hydroxymethylbenzimidazolium bromides as protein tyrosine phosphatase 1В (PTP1В) inhibitors and other targets associated with diabetes mellitus
Spasov A.A., Zhukovskaya O.N., Babkov D.A., Brigadirova A.A., Babkova V.A., Morkovnik A.S., Litvinov R.A., Sokolova E.V.
Russian Chemical Bulletin , 2020
90.
Synthesis and Pharmacological Activity of Trifluoromethyl-Containing Imidazo[1,2-A]Benzimidazoles
Zhukovskaya O.N., Spasov A.A., Kuz’menko T.A., Morkovnik A.S., Kucheryavenko A.F., Anisimova V.A., Salaznikova O.A., Gaidukova K.A., Kuznetsova V.A., Babkov D.A., Grechko O.Y., Eliseeva N.V., Rashchenko A.I.
Pharmaceutical Chemistry Journal , 2018
91.
Synthesis and pharmacological activity of 2-(biphenyl-4-yl)imidazo[1,2-a]benzimidazoles
Spasov A.A., Zhukovskaya O.N., Brigadirova A.A., Abbas H.S., Anisimova V.A., Sysoeva V.A., Rashchenko A.I., Litvinov R.A., Mayka O.Y., Babkov D.A., Morkovnik A.S.
Russian Chemical Bulletin , 2017
92.
Synthesis and Pharmacological Activity of 2,9-Disubstituted Imidazo[1,2-a]Benzimidazole Phenyl- and Alkylthiocarbamides
Anisimova V.A., Zhukovskaya O.N., Spasov A.A., Kuznetsova V.A., Kosolapov V.A., Yakovlev D.S., Solov’eva O.A., Sorotskii D.V., Brigadirova A.A., Vorob’ev E.S.
Pharmaceutical Chemistry Journal , 2016
93.
Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators.
Babkov D.A., Zhukowskaya O.N., Borisov A.V., Babkova V.A., Sokolova E.V., Brigadirova A.A., Litvinov R.A., Kolodina A.A., Morkovnik A.S., Sochnev V.S., Borodkin G.S., Spasov A.A.
Bioorganic and Medicinal Chemistry Letters , 2019
94.
Prototropic equilibrium in 1(11)H-2, 3, 4, 5-tetrahydro[1, 3]diazepino[1, 2-a]benzimidazole, synthesis and pharmacological properties of its N-substituted derivatives
Morkovnik A.S., Spasov A.A., Kuz’menko T.A., Kucheryavenko A.F., Divaeva L.N., Koshchienko Y.V., Anisimova V.A., Kuzmina L.G., Rogova N.V., Kuznetsova V.A., Chepljaeva N.I., Solovyova O.A., Taran A.S., Vorobiev E.S., Aleshin D.A., et. al.
Russian Chemical Bulletin , 2015
95.
Antiglycation and antioxidant potential of novel imidazo[4,5-b]pyridine benzohydrazones
Taha M., Alkadi K.A., Ismail N.H., Imran S., Adam A., Kashif S.M., Shah S.A., Jamil W., Sidiqqui S., Khan K.M.
Arabian Journal of Chemistry , 2019
96.
Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies
Taha M., Ismail N.H., Imran S., Rashwan H., Jamil W., Ali S., Kashif S.M., Rahim F., Salar U., Khan K.M.
Bioorganic Chemistry , 2016
98.
Benzothiazole Derivatives: Novel Inhibitors of Methylglyoxal Mediated Glycation of Proteins In Vitro
Abbasi S., Mirza S., Rasheed S., Hussain S., Khan J., Khan K., Perveen S., Choudhary M.
Medicinal Chemistry , 2014
99.
rcr_91_6_RCR5041bib99
Okuda
J. Heterocycl. Chem. , 2013
101.
rcr_91_6_RCR5041bib101
Matos
Org. Chem. , 2017
102.
Synthesis, characterization and vasculoprotective effects of nitric oxide-donating derivatives of chrysin
Zou X., Peng S., Hu C., Tan L., Yuan Q., Deng H., Li Y.
Bioorganic and Medicinal Chemistry , 2010
104.
rcr_91_6_RCR5041bib104
Nayak
EXCLI J. , 2017
108.
rcr_91_6_RCR5041bib108
Jayashree
Der Pharma Chemica , 2012
109.
rcr_91_6_RCR5041bib109
Wang
RSC Adv. , 2017
110.
Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation
Imran A., Tariq Shehzad M., al Adhami T., Miraz Rahman K., Hussain D., Alharthy R.D., Shafiq Z., Iqbal J.
Bioorganic Chemistry , 2021
111.
Bis-coumarins; non-cytotoxic selective urease inhibitors and antiglycation agents
Salar U., Nizamani A., Arshad F., Khan K.M., Fakhri M.I., Perveen S., Ahmed N., Choudhary M.I.
Bioorganic Chemistry , 2019
112.
Antiglycation activity of lipophilized epigallocatechin gallate (EGCG) derivatives
Wang M., Zhang X., Zhong Y.J., Perera N., Shahidi F.
Food Chemistry , 2016
113.
Functionalized furo[3,2-c]coumarins as anti-proliferative, anti-lipolytic, and anti-inflammatory compounds: Synthesis and molecular docking studies
Fattah T.A., Saeed A., Al-Hiari Y.M., Kasabri V., Almasri I.M., AlAlawi S., Larik F.A., Channar P.A.
Journal of Molecular Structure , 2019
114.
Synthesis and antiglycation potentials of bergenin derivatives
Vijaya Kumar T., Tiwari A.K., Robinson A., Suresh Babu K., Sateesh Chandra Kumar R., Anand Kumar D., Zehra A., Madhusudna Rao J.
Bioorganic and Medicinal Chemistry Letters , 2011
115.
6‐Nitroazolo[1,5‐a]pyrimidin‐7(4H)‐ones as Antidiabetic Agents
Spasov A.A., Babkov D.A., Sysoeva V.A., Litvinov R.A., Shamshina D.D., Ulomsky E.N., Savateev K.V., Fedotov V.V., Slepukhin P.A., Chupakhin O.N., Charushin V.N., Rusinov V.L.
Archiv der Pharmazie , 2017
116.
Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.
Savateev K., Fedotov V., Butorin I., Eltsov O., Slepukhin P., Ulomsky E., Rusinov V., Litvinov R., Babkov D., Khokhlacheva E., Radaev P., Vassiliev P., Spasov A.
European Journal of Medicinal Chemistry , 2020
117.
Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c ][1,2,4]-triazines and Pyrazolo[5,1-c ][1,2,4]triazines as Potential Antidiabetic Agents
Rusinov V.L., Sapozhnikova I.M., Bliznik A.M., Chupakhin O.N., Charushin V.N., Spasov A.A., Vassiliev P.M., Kuznetsova V.A., Rashchenko A.I., Babkov D.A.
Archiv der Pharmazie , 2017
118.
rcr_91_6_RCR5041bib118
Spasov
Eksperim. Klinich. Farmokog. , 2021
119.
Prediction of Antiglycation Activity by Calculating the Energies of Frontier Molecular Orbitals for New 4-Hydroxy-1,4-Dihydroazolo[5,1-c]-1,2,4-Triazines Used as an Example
Litvinov R.A., Drokin R.A., Shamshina D.D., Kalenova M.Y., Usmianova L.E., Muraveva E.A., Vasiliev P.M., Voinkov E.K., Ulomskiy E.N., Spasov A.A., Rusinov V.L.
Russian Journal of Bioorganic Chemistry , 2020
120.
Synthesis and biological activity of 3-guanidino-6-R-imidazo[1,2-b]- and 6-guanidino-3-R-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazines
Ishmetova R.I., Ignatenko N.K., Korotina A.V., Ganebnykh I.N., Slepukhin P.A., Babkova V.A., Gerasimova N.A., Evstigneeva N.P., Zilberberg N.V., Kungurov N.V., Rusinov G.L., Spasov A.A., Chupakhin O.N.
Russian Chemical Bulletin , 2018
121.
Synthesis and Antidiabetic Activity of Thiazolo[2,3-f]Purine Derivatives and Their Analogs
Spasov A.A., Khaliullin F.A., Babkov D.A., Timirkhanova G.A., Kuznetsova V.A., Naumenko L.V., Muleeva D.R., Maika O.Y., Prokhorova T.Y., Sturova E.A.
Pharmaceutical Chemistry Journal , 2017
122.
rcr_91_6_RCR5041bib122
Nair
Bioorg. Chem. , 2020
123.
Dual anti‐inflammatory and antiglycation propensities of a potentially novel class of functionalized fluoroquinolones
Hamdan A., Kasabri V., Al‐Hiari Y., Arabiyat S., AlAlawi S., Bustanji Y.
Journal of Heterocyclic Chemistry , 2019
124.
rcr_91_6_RCR5041bib124
Arabiyat
Jordan J. Pharm. Sci. , 2020